Clinical Neuropsychologist Online
  • Clinical Neuropsychologist
    • Neuropsychological Assessment
      • What is Clinical Neuropsychology?
      • Our Clinical Neuropsychology Consults
      • Post-COVID Neuropsychological Assessment
      • Neuropsychological Rehabilitation Online & in Hong Kong
    • Our Clinical Neuropsychologist
      • Clinical Neuropsychologist Referral
      • Clinical Neuropsychology Intake Upload
    • Clinical Neuropsychologist Online Appointments
      • Intake Appointment
      • Neuropsychologist Consult
      • Neuropsychology Feedback Session
  • Neuropsychology Knowledgebase
    • Acquired Brain Injury
    • Alzheimer’s Disease Neuropsychology
    • Dementia Neuropsychology
    • Memory Neuropsychology
    • Neuroanatomy & Neuroradiology
    • Neuropsychological Assessment
    • Neuropsychological Disorders
    • Neuropsychological Rehabilitation
    • Traumatic Brain Injury
  • Neuropsychology CPD
    • Latest Journal Articles
    • Cognitive Neuropsychology
    • Dementia
    • Neuro Podcasts
    • Neuroimaging
    • Neuropsychology (general)
    • Neurorehabilitation
    • Neuroscience
    • Paediatric Neuropsychology
  • Neuropsychology Courses
  • Newsletter
  • Brain Lounge
Select Page

Technology that CARES: Enhancing dementia care through everyday technologies

by Clinical Neuropsychologist | Thursday, November 7, 2024 | Dementia

Abstract “Everyday technologies” have long been suggested as digital tools to improve life for and enhance care of persons with Alzheimer’s disease and related dementias (ADRD). Within this realm, there is a need to balance potential drawbacks of technologies...

SV2A PET shows hippocampal synaptic loss in cognitively unimpaired APOE ε4/ε4 homozygotes

by Clinical Neuropsychologist | Wednesday, October 30, 2024 | Dementia

Abstract INTRODUCTION We investigated hippocampal synaptic density using synaptic vesicle 2A positron emission tomography (PET), and its association with amyloid beta (Aβ) and cognitive performance in healthy apolipoprotein E (APOE) ε4 carriers. METHODS Synaptic...

Neurophysiological biomarkers of Alzheimer’s disease: In vivo evaluation of synaptic dysfunction

by Clinical Neuropsychologist | Tuesday, October 29, 2024 | Dementia

Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Francesco Motolese, Raffaele Dubbioso, Federico Ranieri,...

2024 AA criteria for Alzheimer’s disease diagnosis: Mainly anchored at Aβ not tau

by Clinical Neuropsychologist | Tuesday, October 29, 2024 | Dementia

Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Alexis Moscoso, Nicolas Villain | October 29, 2024 Wiley:...

Latent change‐on‐change between amyloid accumulation and cognitive decline

by Clinical Neuropsychologist | Tuesday, October 29, 2024 | Dementia

Abstract INTRODUCTION While the influence of cross-sectional β-amyloid (Aβ) on longitudinal changes in cognition is well established, longitudinal change-on-change between Aβ and cognition is less explored. METHODS A series of bivariate latent change score models...
« Older Entries
Next Entries »

Posts by Category

  • Cognitive Neuropsychology
  • Dementia
  • Neuro Podcasts
  • Neuroimaging
  • Neuropsychology (general)
  • Neurorehabilitation
  • Neuroscience
  • Paediatric Neuropsychology

Neuropsychology Newsletter &
Interest List

S U B S C R I B E

  • X
  • RSS
© PsyAsia Neuropsychology. Clinical Neuropsychologist Hong Kong & Online. Part of the Psychology1 Group. All Rights Reserved.
DISCLAIMER: We are not responsible for any inaccuracies at this site. No medical advice is being offered to you personally.
No medical contract is formed by you visiting PsyAsia Neuropsychology. 🕉️🔱☸️